Yamamoto-Furusho Jesus K, Takahashi-Monroy Takeshi, Vergara-Fernandez Omar, Reyes Edgardo, Uscanga Luis
Department of Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
World J Gastroenterol. 2006 Jun 7;12(21):3406-9. doi: 10.3748/wjg.v12.i21.3406.
To assess the prevalence and clinical value of p-ANCA in a sample of Mexican ulcerative colitis (UC) patients.
In a prospective, IRB-approved protocol, p-ANCA was determined in 80 patients with UC (mean age, 32 +/- 12.9 years). The severity and extension of disease were determined by clinical methods, searching a statistical association with p-ANCA status.
p-ANCA were detected in 41 (51%) patients. Severity of disease was the only clinical variable statistically associated with their presence (P < 0.0001; OR = 9; CI 95% = 3.2-24.7).
The prevalence of p-ANCA was similar to that reported in other countries. Their presence was associated to UC severity, but offered no more information than the obtained by clinical methods.
评估抗中性粒细胞胞浆抗体(p-ANCA)在一组墨西哥溃疡性结肠炎(UC)患者中的患病率及临床价值。
在一项经机构审查委员会(IRB)批准的前瞻性研究方案中,对80例UC患者(平均年龄32±12.9岁)检测p-ANCA。通过临床方法确定疾病的严重程度和范围,并寻找与p-ANCA状态的统计学关联。
41例(51%)患者检测到p-ANCA。疾病严重程度是唯一与p-ANCA存在具有统计学关联的临床变量(P<0.0001;比值比[OR]=9;95%置信区间[CI]=3.2-24.7)。
p-ANCA的患病率与其他国家报道的相似。其存在与UC严重程度相关,但并未提供比临床方法更多的信息。